Peptide
Prostatilen
SaveA peptide extract from bovine prostate tissue, approved in Russia for chronic prostatitis and benign prostatic hyperplasia.
Quick verdict
Approved and widely used in Russia/CIS for prostate conditions. Not recognized by Western regulatory agencies. Evidence quality is variable.
Evidence score
A rough internal score reflecting quantity, quality, and consistency of human evidence. Not a clinical recommendation.
What the research shows
Multiple Russian clinical studies for chronic prostatitis and BPH. Limited international publication. Not evaluated by EMA or FDA.
Benefits
- Approved in Russia for chronic prostatitis
- Some clinical data for BPH symptom improvement
- Generally well tolerated in published studies
Dosage notes
Russian protocols: 30–50 mg rectal suppositories daily for 5–10 days, or 5 mg IM daily.
Side effects
- Local irritation with suppositories
- Allergic reactions rare
- Injection-site pain
Who should be cautious
Animal-derived biological. Not approved outside Russia/CIS. Quality varies by manufacturer.
What this page cannot tell you
Evidence is predominantly from Russian literature with variable methodology. Not independently validated internationally.
Leaderboard scores
- Pain20
Write a review
Sign in to write a review.